A detailed history of Efg Asset Management (North America) Corp. transactions in Vericel Corp stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 47,312 shares of VCEL stock, worth $2.12 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
47,312
Previous 44,643 5.98%
Holding current value
$2.12 Million
Previous $1.59 Million 54.88%
% of portfolio
0.43%
Previous 0.31%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$32.52 - $52.33 $86,795 - $139,668
2,669 Added 5.98%
47,312 $2.46 Million
Q4 2023

Feb 08, 2024

SELL
$30.85 - $37.09 $34,212 - $41,132
-1,109 Reduced 2.42%
44,643 $1.59 Million
Q3 2023

Nov 02, 2023

BUY
$31.69 - $39.25 $787,559 - $975,441
24,852 Added 118.91%
45,752 $1.53 Million
Q2 2023

Jul 28, 2023

BUY
$29.0 - $38.37 $606,100 - $801,933
20,900 New
20,900 $785,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.12B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.